Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

312
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
312
Tissue Transplantation01:24

Tissue Transplantation

875
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
875
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.4K
Overview
83.4K
Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

845
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
845
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

290
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function.

Frontiers in transplantation·2026
Same author

Glucagon-Like Peptide-1 Agonist vs. Placebo and Pulmonary Decline After Open-Heart Surgery: A Substudy of the GLORIOUS Randomised Clinical Trial.

Acta anaesthesiologica Scandinavica·2026
Same author

Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.

European journal of preventive cardiology·2026
Same author

Perioperative Antibiotic Prophylaxis in Burn Patients: Protocol for a Systematic Review.

Acta anaesthesiologica Scandinavica·2026
Same author

Novel Partial Loss-of-function STAT3-variant as Cause of Hyper-IgE-Syndrome in a Danish Family with Variable Expressivity.

Journal of clinical immunology·2026
Same author

Interferon-gamma release assay screening before solid organ transplantation in a low-incidence country: a prospective single-center cohort study.

Scientific reports·2026

Related Experiment Video

Updated: Jan 10, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.6K

[Vaccination in solid organ transplantation].

Sebastian Rask Hamm1, Christina Ekenberg2, Hans Henrik Lawaetz Schultz3

  • 1Afdeling for Infektionssygdomme, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger
|November 21, 2025
PubMed
Summary
This summary is machine-generated.

Vaccination is recommended for solid organ transplant (SOT) candidates. Despite weaker immune responses, SOT recipients who are vaccinated have a lower risk of severe infections and related diseases.

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.2K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.6K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.2K

Area of Science:

  • Immunology
  • Transplant Medicine
  • Infectious Disease Prevention

Background:

  • Solid organ transplant (SOT) recipients require immunosuppressive therapy, increasing their vulnerability to infections.
  • Vaccination responses in SOT recipients are often weaker than in the general population.
  • International and Danish guidelines recommend pre-transplant vaccination for SOT candidates.

Purpose of the Study:

  • To review the evidence on vaccination in SOT recipients.
  • To assess the association between vaccination and severe infection-related disease in SOT recipients.
  • To evaluate the impact of a national vaccination program for SOT candidates.

Main Methods:

  • Systematic review of existing literature on vaccination in SOT recipients.
  • Analysis of data from a national vaccination program for SOT candidates in Denmark.

Main Results:

  • Vaccination in SOT recipients is associated with a reduced risk of severe infection-related disease.
  • Despite diminished immunological responses, the protective effect of vaccines is evident.
  • The Danish national vaccination program for SOT candidates demonstrates high vaccination coverage.

Conclusions:

  • Pre-transplant vaccination is a crucial strategy for mitigating infection risks in SOT recipients.
  • Vaccination programs are effective in improving vaccine uptake among SOT candidates.
  • Further research may explore optimizing vaccine strategies for immunocompromised populations.